Fiduciary Alliance
DFTX icon

Fiduciary Alliance’s Definium Therapeutics DFTX Stock Holding History

Fiduciary Alliance’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$228K Hold
6,000
– – 0.02% 461
2026
Q2 		$282K Buy
+6,000
New +$148K 0.02% 454

Other funds holding DFTX

Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FSBI
Fearless Solutions (Best Invest) San Antonio, Texas $197M AUM 23.54% 1-Year Est. Return

Fiduciary Alliance's DFTX Position: Q3 2026 in Review

Fiduciary Alliance held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 6,000 shares worth $228K. The position accounts for 0.02% of the portfolio, ranked #461.

Fiduciary Alliance first reported a position in DFTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $282K in Q2 2026. 33 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Fiduciary Alliance held 6,000 shares of Definium Therapeutics worth $228K as of Q3 2026.
  • Fiduciary Alliance left its Definium Therapeutics share count unchanged in Q3 2026.
  • Definium Therapeutics made up 0.02% of Fiduciary Alliance's portfolio in Q3 2026, its #461 holding.
  • Fiduciary Alliance first reported a position in Definium Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Fiduciary Alliance's Definium Therapeutics position peaked at $282K in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.